Andrea Corcoran

Chief Financial Officer, Executive Vice President, LegalatAtea Pharmaceuticals· In proxies 2021–2025

Pay in FY2025-12% from the year before · Atea Pharmaceuticals stock +6.6% the same year

Andrea Corcoran was paid $1.7M in FY2025 (Dec), down 12%. Atea Pharmaceuticals stock rose 6.6% that year.

Pay$100 in the stock at the end of FY20 → $9

Pay is from the Summary Compensation Table of each Atea Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

AVIR
Atea PharmaceuticalsPublic company · 5 yr
- Chief Financial Officer, Executive Vice President, Legal2021 – Present · 5 yrStock in role -88%

Roles come from the proxy statements of each company.

Activity

Pay
Atea Pharmaceuticals CFO pay fell 12% to $1.7M. The stock rose 7% in FY2025 (Dec).
DEF 14AApr 27, 2026
Pay
Atea Pharmaceuticals CFO pay fell 77% to $2.0M. The stock fell 46% in FY2022 (Dec).
DEF 14AApr 29, 2025

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?